Results 81 to 90 of about 24,846 (173)

Successful Treatment with Sulbactam-Durlobactam for Severe Acute Pancreatitis Complicated by Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Infection at Multiple Sites: A Case Report. [PDF]

Infect Drug Resist
Ge Z, Li L, Wang L, Liu D, Liu Y.
europepmc   +1 more source

Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant <i>Enterobacterales</i>. [PDF]

Microbiol Spectr
Meng Q, Xu C, Li W, Shen K, Huang X, Fu X, Zhou L, Chen Y, Hu F, Wang H.   +9 more
europepmc   +1 more source

In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates. [PDF]

J Antimicrob Chemother
Tascini C, Bianco G, Bonomo RA, Gaibani P.   +3 more
europepmc   +1 more source

Comparative effectiveness of ertapenem versus other empirical antibiotics in elderly patients with complicated intra-abdominal infection: a real-world inverse probability of treatment weighting study. [PDF]

Front Cell Infect Microbiol
Sun Y, Guo Y, Cui H, Jiang Y, Yu Q.
europepmc   +1 more source

Antibacterial activity of enmetazobactam against <i>Acinetobacter</i> spp.: a molecular dissection of mechanism of action and resistance determinants. [PDF]

Antimicrob Agents Chemother
Báez-Barroso G-A, Rodríguez-Coello A, Vázquez-Ucha JC, López-Argüello S, Outeda-García M, González-Pinto L, García-Pose A, Guijarro-Sánchez P, Alonso-García I, Lence E, González-Bello C, Oliver A, Arca-Suárez J, Moya B, Bou G, Beceiro A, Spanish National Acinetobacter spp. 2020 Study Group.   +16 more
europepmc   +1 more source

Comparative effectiveness of two antimicrobial regimens for the treatment of pan-drug-resistant <i>Acinetobacter baumannii</i> infections: results from the DESPAIR study. [PDF]

Antimicrob Agents Chemother
Pontikis K, Karaiskos I, Sakagianni A, Mouloudi E, Tsigou E, Gkoufa A, Michelidou S, Mouratidou K, Gavala A, Routsi C, Karakonstantis S, Michalea S, Ampelioti S, Katsarou T, Papathanasiou A, Pirounaki M, Anastogiannis C, Koutsoukou A, Giamarellou H, Daikos GL, DESPAIR Study Group.   +20 more
europepmc   +1 more source

Comparative effectiveness of antimicrobial regimens for pneumonia caused by drug-resistant Acinetobacter baumannii: a network meta-analysis including cefiderocol and inhaled therapies. [PDF]

BMC Infect Dis
Ai MY, Chang WL.
europepmc   +1 more source

Treating Extensively Drug-Resistant Acinetobacter baumannii: Considerations for Host Characteristics and Type of Infections. [PDF]

Pathogens
Geladari A, Kouroupis D, Vafeidou K, Liakos V, Magoudi M, Papathanasiou AI, Iosifidis E, Roilides E, Antachopoulos C, Pyrpasopoulou A.   +9 more
europepmc   +1 more source

Effectiveness and Safety of High-Dose versus Standard-Dose Cefoperazone-Sulbactam in Severe Infections: A Multicenter Retrospective Study. [PDF]

Infect Drug Resist
Li CH, Hsu CK, Lai CC, Liu JW, Tang HJ, Liao KM, Chang PC, Ku YH, Chiu YH, Chiu CT.   +9 more
europepmc   +1 more source

Evaluation of sulbactam/durlobactam activity and synergy against highly drug-resistant <i>Acinetobacter baumannii</i> strains. [PDF]

JAC Antimicrob Resist
Halim J, Bouzo J, Carabetta VJ.
europepmc   +1 more source